Cheng Wang

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Cytotoxic Agents. Top assignees: Merck Sharp + Dohme Corp., Opko Health, Inc., Schering Corporation. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Wang. Retrieved from https://idiyas.com/inventor/cheng-wang-93gxdvhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 5)

% Patents Active = 76.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 7.5

ph-index = 11

Forward Citations = 250(Granted Patents)

Location History:

West Point, PA (US) (2015)
King of Prussia, PA (US) (2009 - 2016)
Summit, NJ (US) (2006 - 2018)
Fort Washington, PA (US) (2014 - 2023)

Company Filing History:

11 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Pyrimidone Derivatives

Cytotoxic Agents

CGRP Receptor Antagonists

Piperidinone Carboxamide

Ether Benzotriazole

NK1 Antagonists

Tetrahydroquinazoline

Inhibitors of Checkpoint Kinases

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12258329 - Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells (2025-03-25),

2. 11648250 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2023-05-16),

3. 10272077 - Piperidinone carboxamide azaindane CGRP receptor antagonists (2019-04-30),

4. 9969711 - [object Object] (2018-05-15),

5. 9833448 - Piperidinone carboxamide azaindane CGRP receptor antagonists (2017-12-05),

6. 9688693 - [object Object] (2017-06-27),

7. 9499545 - Piperidinone carboxamide azaindane CGRP receptor antagonists (2016-11-22),

8. 9499541 - Piperidinone carboxamide indane CGRP receptor antagonists (2016-11-22),

9. 9469629 - [object Object] (2016-10-18),

10. 8975286 - Ether benzotriazole derivatives (2015-03-10),

11. 8912210 - Piperidinone carboxamide azaindane CGRP receptor antagonists (2014-12-16),

12. 8883807 - Piperidinone carboxamide indane CGRP receptor antagonists (2014-11-11),

13. 8796299 - NK1 antagonists (2014-08-05),

14. 8785481 - Ether benzotriazole derivatives (2014-07-22),

15. 8754216 - NK1 antagonists (2014-06-17),

Title: The Innovative Journey of Cheng Wang

Introduction: Cheng Wang, a visionary inventor based in Summit, NJ, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Cheng Wang's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary renewable energy storage system, and a novel cybersecurity solution for IoT devices.

Career Highlights: With a background in computer science and engineering, Cheng Wang has a successful track record of developing innovative solutions that have garnered international recognition. His patents have been instrumental in shaping the future of various industries.

Collaborations: Cheng Wang has collaborated with leading tech companies, research institutions, and universities to further advance his inventions. His collaborative efforts have resulted in the development of cutting-edge technologies that have transformed the way we live and work.

Conclusion: Cheng Wang's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventions continue to inspire and drive progress in the ever-evolving landscape of innovation.

Profile summary based on public USPTO records.